0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-4C18181
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2024
BUY CHAPTERS

Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2024

Code: QYRE-Auto-4C18181
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Maternal Pertussis Vaccine for Newborn Protection Market

The global Maternal Pertussis Vaccine for Newborn Protection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include GlaxoSmithKline, Sanofi Pasteur, Intravacc, Zhifei Biological, Walvax, Minhai Biological, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Maternal Pertussis Vaccine for Newborn Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maternal Pertussis Vaccine for Newborn Protection.
The Maternal Pertussis Vaccine for Newborn Protection market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Maternal Pertussis Vaccine for Newborn Protection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Maternal Pertussis Vaccine for Newborn Protection Market Report

Report Metric Details
Report Name Maternal Pertussis Vaccine for Newborn Protection Market
Segment by Type
Segment by Application
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Sanofi Pasteur, Intravacc, Zhifei Biological, Walvax, Minhai Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Maternal Pertussis Vaccine for Newborn Protection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Maternal Pertussis Vaccine for Newborn Protection Market report?

Ans: The main players in the Maternal Pertussis Vaccine for Newborn Protection Market are GlaxoSmithKline, Sanofi Pasteur, Intravacc, Zhifei Biological, Walvax, Minhai Biological

What are the Application segmentation covered in the Maternal Pertussis Vaccine for Newborn Protection Market report?

Ans: The Applications covered in the Maternal Pertussis Vaccine for Newborn Protection Market report are Hospital, Centers for Disease Control and Prevention, Others

What are the Type segmentation covered in the Maternal Pertussis Vaccine for Newborn Protection Market report?

Ans: The Types covered in the Maternal Pertussis Vaccine for Newborn Protection Market report are Acellular Pertussis Vaccine, Whole-cell Pertussis Vaccine

Recommended Reports

Pertussis & DTP Vaccines

Broad Vaccine Markets

Vaccine Technologies

1 Maternal Pertussis Vaccine for Newborn Protection Market Overview
1.1 Product Definition
1.2 Maternal Pertussis Vaccine for Newborn Protection by Type
1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024-2030)
1.2.2 Acellular Pertussis Vaccine
1.2.3 Whole-cell Pertussis Vaccine
1.3 Maternal Pertussis Vaccine for Newborn Protection by Application
1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts
1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue 2019-2030
1.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales 2019-2030
1.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Maternal Pertussis Vaccine for Newborn Protection Market Competition by Manufacturers
2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application
2.7 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Enter into This Industry
2.8 Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends
2.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue
2.8.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Maternal Pertussis Vaccine for Newborn Protection Market Scenario by Region
3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2019-2030
3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2019-2024
3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2025-2030
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2019-2030
3.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2019-2024
3.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2025-2030
3.4 North America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2030)
3.4.3 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2030)
3.5.3 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Region
3.6.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2019-2030)
3.6.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.7.1 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2030)
3.7.3 Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.8.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2019-2030)
4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2019-2024)
4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2025-2030)
4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2019-2030)
4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2019-2030)
4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2019-2024)
4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2025-2030)
4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2019-2030)
4.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2019-2030)
5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2019-2024)
5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2025-2030)
5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2019-2030)
5.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2019-2030)
5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2019-2024)
5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2025-2030)
5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2019-2030)
5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Intravacc
6.3.1 Intravacc Company Information
6.3.2 Intravacc Description and Business Overview
6.3.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.3.5 Intravacc Recent Developments/Updates
6.4 Zhifei Biological
6.4.1 Zhifei Biological Company Information
6.4.2 Zhifei Biological Description and Business Overview
6.4.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.4.5 Zhifei Biological Recent Developments/Updates
6.5 Walvax
6.5.1 Walvax Company Information
6.5.2 Walvax Description and Business Overview
6.5.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.5.5 Walvax Recent Developments/Updates
6.6 Minhai Biological
6.6.1 Minhai Biological Company Information
6.6.2 Minhai Biological Description and Business Overview
6.6.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.6.5 Minhai Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis
7.2 Maternal Pertussis Vaccine for Newborn Protection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process
7.4 Maternal Pertussis Vaccine for Newborn Protection Sales and Marketing
7.4.1 Maternal Pertussis Vaccine for Newborn Protection Sales Channels
7.4.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
7.5 Maternal Pertussis Vaccine for Newborn Protection Customers
8 Maternal Pertussis Vaccine for Newborn Protection Market Dynamics
8.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
8.2 Maternal Pertussis Vaccine for Newborn Protection Market Drivers
8.3 Maternal Pertussis Vaccine for Newborn Protection Market Challenges
8.4 Maternal Pertussis Vaccine for Newborn Protection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application
 Table 12. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Maternal Pertussis Vaccine for Newborn Protection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Maternal Pertussis Vaccine for Newborn Protection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2019-2024) & (Dose)
 Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2019-2024)
 Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2025-2030) & (Dose)
 Table 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2025-2030)
 Table 21. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2019-2024)
 Table 23. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2025-2030)
 Table 25. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2024) & (Dose)
 Table 27. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2025-2030) & (Dose)
 Table 28. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2024) & (Dose)
 Table 32. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2025-2030) & (Dose)
 Table 33. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2019-2024) & (Dose)
 Table 37. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2025-2030) & (Dose)
 Table 38. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2024) & (Dose)
 Table 42. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2025-2030) & (Dose)
 Table 43. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2019-2024) & (Dose)
 Table 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2025-2030) & (Dose)
 Table 48. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Type (2019-2024)
 Table 51. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Type (2025-2030)
 Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2019-2024)
 Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2025-2030)
 Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2019-2024)
 Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2025-2030)
 Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Application (2019-2024)
 Table 61. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Dose) by Application (2025-2030)
 Table 62. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2019-2024)
 Table 63. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2025-2030)
 Table 64. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2019-2024)
 Table 67. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2025-2030)
 Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2025-2030)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Sanofi Pasteur Company Information
 Table 76. Sanofi Pasteur Description and Business Overview
 Table 77. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product
 Table 79. Sanofi Pasteur Recent Developments/Updates
 Table 80. Intravacc Company Information
 Table 81. Intravacc Description and Business Overview
 Table 82. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product
 Table 84. Intravacc Recent Developments/Updates
 Table 85. Zhifei Biological Company Information
 Table 86. Zhifei Biological Description and Business Overview
 Table 87. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product
 Table 89. Zhifei Biological Recent Developments/Updates
 Table 90. Walvax Company Information
 Table 91. Walvax Description and Business Overview
 Table 92. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Walvax Maternal Pertussis Vaccine for Newborn Protection Product
 Table 94. Walvax Recent Developments/Updates
 Table 95. Minhai Biological Company Information
 Table 96. Minhai Biological Description and Business Overview
 Table 97. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product
 Table 99. Minhai Biological Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Maternal Pertussis Vaccine for Newborn Protection Distributors List
 Table 103. Maternal Pertussis Vaccine for Newborn Protection Customers List
 Table 104. Maternal Pertussis Vaccine for Newborn Protection Market Trends
 Table 105. Maternal Pertussis Vaccine for Newborn Protection Market Drivers
 Table 106. Maternal Pertussis Vaccine for Newborn Protection Market Challenges
 Table 107. Maternal Pertussis Vaccine for Newborn Protection Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection
 Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type: 2023 & 2030
 Figure 4. Acellular Pertussis Vaccine Product Picture
 Figure 5. Whole-cell Pertussis Vaccine Product Picture
 Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Centers for Disease Control and Prevention
 Figure 10. Others
 Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Maternal Pertussis Vaccine for Newborn Protection Sales (2019-2030) & (Dose)
 Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) & (2019-2030)
 Figure 15. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered
 Figure 16. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2023
 Figure 17. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players: Market Share by Revenue in Maternal Pertussis Vaccine for Newborn Protection in 2023
 Figure 19. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2019-2030)
 Figure 22. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2019-2030)
 Figure 23. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2019-2030)
 Figure 26. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2019-2030)
 Figure 34. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2019-2030)
 Figure 53. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2019-2030)
 Figure 56. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2019-2030)
 Figure 57. Maternal Pertussis Vaccine for Newborn Protection Value Chain
 Figure 58. Maternal Pertussis Vaccine for Newborn Protection Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure